User profiles for Joan Montaner
 | Joan MontanerNeurovascular Lab, VHIR, Barcelona. Neurology Department & IBIS. Macarena Hospital … Verified email at vhir.org Cited by 39076 |
[HTML][HTML] Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke
…, SR Ford, J Alvarez-Sabin, J Montaner… - … England Journal of …, 2004 - Mass Medical Soc
Background Transcranial Doppler ultrasonography that is aimed at residual obstructive
intracranial blood flow may help expose thrombi to tissue plasminogen activator (t-PA). Our …
intracranial blood flow may help expose thrombi to tissue plasminogen activator (t-PA). Our …
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage
…, AD Mendelow, C Molina, J Montaner… - … journal of stroke, 2014 - journals.sagepub.com
Background Intracerebral hemorrhage (ICH) accounted for 9% to 27% of all strokes worldwide
in the last decade, with high early case fatality and poor functional outcome. In view of …
in the last decade, with high early case fatality and poor functional outcome. In view of …
Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke
J Montaner, CA Molina, J Monasterio, S Abilleira… - Circulation, 2003 - Am Heart Assoc
Background— Matrix metalloproteinase (MMP) expression is related to blood brain barrier
disruption after cerebral ischemia. Moreover, MMP inhibitors reduce hemorrhagic …
disruption after cerebral ischemia. Moreover, MMP inhibitors reduce hemorrhagic …
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
…, E Martínez-Sáez, C Mawrin, J Montaner… - The Lancet …, 2022 - thelancet.com
Background Cerebral amyloid angiopathy (CAA) is an age-related small vessel disease,
characterised pathologically by progressive deposition of amyloid β in the cerebrovascular wall. …
characterised pathologically by progressive deposition of amyloid β in the cerebrovascular wall. …
[HTML][HTML] Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies
Background Various genome-wide association studies (GWAS) have been done in ischaemic
stroke, identifying a few loci associated with the disease, but sample sizes have been …
stroke, identifying a few loci associated with the disease, but sample sizes have been …
MMP-9–positive neutrophil infiltration is associated to blood–brain barrier breakdown and basal lamina type iv collagen degradation during hemorrhagic …
…, M Hernández-Guillamon, EH Lo, J Montaner - Stroke, 2008 - Am Heart Assoc
Background and Purpose— An abnormal expression of some matrix metalloproteinases (MMPs)
is related with hemorrhagic transformation events after stroke. Our aim was to …
is related with hemorrhagic transformation events after stroke. Our aim was to …
Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke
…, M Ribó, CA Molina, EH Lo, J Montaner - Stroke, 2006 - Am Heart Assoc
Background and Purpose— Abnormal expression of some matrix metalloproteinases (MMP)
has shown to play a deleterious role in brain injury in experimental models of cerebral …
has shown to play a deleterious role in brain injury in experimental models of cerebral …
Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen …
Background and Purpose— We sought to evaluate the effects of administration of
microbubbles (MBs) on the beginning, speed, and degree of middle cerebral artery (MCA) …
microbubbles (MBs) on the beginning, speed, and degree of middle cerebral artery (MCA) …
Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment
J Montaner, J Alvarez-Sabín, C Molina, A Anglés… - Stroke, 2001 - Am Heart Assoc
Background and Purpose— Uncontrolled expression of matrix metalloproteinases (MMPs)
can result in tissue injury and inflammation. In animal models of cerebral ischemia, the …
can result in tissue injury and inflammation. In animal models of cerebral ischemia, the …
Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator–treated patients
J Alvarez-Sabín, CA Molina, J Montaner, JF Arenillas… - Stroke, 2003 - Am Heart Assoc
Background and Purpose— We sought to investigate the impact of hyperglycemia before
reperfusion on long-term outcome in patients treated with intravenous tissue plasminogen …
reperfusion on long-term outcome in patients treated with intravenous tissue plasminogen …